Effects of Myofascial Massage and Patient-therapist Communication Levels on Shoulder Muscle Properties in Breast Cancer Survivors With Myofascial Pain

October 8, 2025 updated by: David B Lipps, PhD, University of Michigan

The objective of the proposed study is to assess how myofascial massage alters stiffness and microvascular perfusion of shoulder muscles and how these changes are influenced by patient-therapist interactions.

The primary hypothesis is that stiffness of shoulder muscles will be decreased, and microvascular perfusion will be increased after a 30-minute myofascial massage, and that the addition of patient-therapist communication levels will result in greater changes with certain levels.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Please note that there are certain details left off of this registration in order to collect information regarding certain aspects of the trial. These details (approved by the IRB) will be updated at the end of the trial.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Previous unilateral breast cancer diagnosis
  • Treatment for primary breast cancer was completed 3 months to 2 years prior to enrollment (defined as completion of all treatments except oral maintenance therapies)
  • Myofascial pain in upper quadrant of the chest
  • Ability to understand and willingness to sign a written informed consent.

Exclusion Criteria:

  • Chronic neuromuscular or orthopedic injury currently affecting upper extremity function that is unrelated to their cancer diagnosis
  • Currently undergoing physical therapy, occupational therapy or other treatment for side effects related to their cancer diagnosis or other injury to the upper extremity
  • History of fibromyalgia
  • Broken or bruised skin in the chest/shoulder area
  • Diagnosed with metastatic breast cancer
  • Currently receiving treatment for other forms of cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Massage with communication level 1
The therapist and the participant will have this level of communication (known as level 1 here). Further details will be explained at the end of the study.

Participants will have one massage that will last 30 minutes and focus on the chest and shoulder of the side that received the cancer treatment. There will be certain techniques applied during the intervention (per protocol). The timing and order of each element will be varied based on tissue response and patient feedback.

All participants will have ultrasounds and complete surveys prior and after the massage.

Experimental: Massage with communication level 2
The therapist and the participant will have this level of communication (known as level 2). Further details will be explained at the end of the study.

Participants will have one massage that will last 30 minutes and focus on the chest and shoulder of the side that received the cancer treatment. There will be certain techniques applied during the intervention (per protocol). The timing and order of each element will be varied based on tissue response and patient feedback.

All participants will have ultrasounds and complete surveys prior and after the massage.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle stiffness of the pectoralis major
Time Frame: Baseline, post massage (approximately 30 minutes and 60 minutes)
This will be assessed by ultrasound shear wave elastography before and after myofascial massage.
Baseline, post massage (approximately 30 minutes and 60 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle perfusion of the pectoralis major and upper trapezius
Time Frame: Baseline, post massage (approximately 30 minutes and 60 minutes)
This will be assessed by Doppler imaging and superb microvascular imaging before and after myofascial massage.
Baseline, post massage (approximately 30 minutes and 60 minutes)
Change in muscle stiffness of the pectoralis major compared between groups
Time Frame: Baseline, post massage (approximately 30 minutes and 60 minutes)
This will be assessed by ultrasound shear wave elastography and compared between patients randomized to a group with restricted or unrestricted communication with the massage therapist.
Baseline, post massage (approximately 30 minutes and 60 minutes)
Global Satisfaction measured by the Patient Global Impression of Change will be compared between groups at the different communication levels
Time Frame: Approximately 60 minutes (during wait period after massage)
This is a one question that participants chose from Very much improved (0) - Very much worse (6).
Approximately 60 minutes (during wait period after massage)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Lipps, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2024

Primary Completion (Actual)

September 20, 2025

Study Completion (Actual)

September 30, 2025

Study Registration Dates

First Submitted

November 5, 2024

First Submitted That Met QC Criteria

November 5, 2024

First Posted (Actual)

November 7, 2024

Study Record Updates

Last Update Posted (Estimated)

October 10, 2025

Last Update Submitted That Met QC Criteria

October 8, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Myofacial

Clinical Trials on Massage

Subscribe